China is taking on the world’s 10 most expensive medicinesnews2026-03-05T15:00:17+00:00March 5th, 2026|Endpoints News|
Merck KGaA drops two cancer trials on assets from SpringWorks dealnews2026-03-05T14:43:11+00:00March 5th, 2026|Endpoints News|
Novo Nordisk details Irish expansion; EuroAPI’s challenges continuenews2026-03-05T14:23:03+00:00March 5th, 2026|Endpoints News|
How hospitals have shifted from experimenting with AI to justifying its costnews2026-03-05T14:00:48+00:00March 5th, 2026|Endpoints News|
FDA puts PepGen’s Phase 2 muscle disease trial on partial holdnews2026-03-05T12:02:30+00:00March 5th, 2026|Endpoints News|
Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’news2026-03-04T18:31:17+00:00March 4th, 2026|Endpoints News|
FDA’s top operating official Butler to retire, deputy to take over in Aprilnews2026-03-04T18:25:30+00:00March 4th, 2026|Endpoints News|
Bayer continues trimming workforce; AnaptysBio’s spinoff is namednews2026-03-04T15:56:40+00:00March 4th, 2026|Endpoints News|
BIO chief still backs FDA’s Makary despite ‘head-scratcher’ decisionsnews2026-03-04T15:49:33+00:00March 4th, 2026|Endpoints News|
